Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report

Marked worsening of adverse effects and increased chlorpromazine plasma levels were observed in a 25-year-old schizophrenic outpatient who abruptly stopped smoking cigarettes. Presence and severity of adverse effects and chlorpromazine plasma levels correlated directly with tobacco smoking over a 16-month period.